BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » RoosterBio Releases Universal Bioprocess Bags to Streamline Closed System Stem Cell Production
RoosterBio hMSC

RoosterBio Releases Universal Bioprocess Bags to Streamline Closed System Stem Cell Production

December 8, 2016 By Cade Hildreth (CEO) Leave a Comment

RoosterBioRoosterBio is an innovative mesenchymal stem cell (MSC) company that is focusing on democratizing stem cell manufacturing and ushering in a new era of regenerative medicine.  2016 has been a massive year for the company, as it recently announced a collaboration with BioBridge Global, as well as a co-branding partnership with the global filtration, separation and purification leader, Pall Corporation.

Discover class-defining bioproduction tools.

In today’s announcement, RoosterBio announces it is releasing universal bioprocess bags to streamline closed system stem cell production. To learn more, see the full press release, printed with permission from RoosterBio.

To learn more, view my 2016 interview or 2017 interview with Rooster Bio’s Founder and CTO, Dr. Jon Rowley.

bitbio

Engineered by RoosterBio Inc.: Universal bioprocess bags to streamline closed system stem cell production

Innovative bagged media systems drastically reduce manufacturing development timelines and simplify translation into large-scale cell culture platforms.

Frederick, MD, USA, Dec 5, 2016 —RoosterBio Inc announces the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This single use (“SU”) disposable bag system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline culture processes, minimize processing time, significantly decrease production costs, and simplify the transition into scalable platforms for clinical and commercial adult stem cell manufacturing.

RoosterBio’s hMSC High Performance Media is now available in SU disposable bags engineered to be compatible with all major cell therapy/ bioprocessing culture systems, including multi-layer vessels and suspension bioreactors. This flexible media packaging is made with best-in-class film technology and engineered with multiple weld-able or aseptic connection ports to enable rapid integration with scalable bioreactor technologies. With the introduction of this bagged media format, RoosterBio media systems are now instantly compatible with all major 2D and 3D cell culture systems. This system streamlines workflow by eliminating the need to transfer media from bottles to bags for closed system hMSC expansion, and reduces the custom engineering time required for transitioning to scalable cell culture systems.

Pluristyx

Jon Rowley, CEO of RoosterBio stated: “The Stem Cell Therapy field is sorely lacking standards in single use disposables and bioreactor technology, slowing product development timelines throughout the industry. We are commercializing our best in class hMSC bioprocess media systems now in universal single-use bag configurations to further our mission of radically shortening the development timelines for stem cell-based medical products. Our creative engineers designed media bags (patent pending) to connect to all Cell Therapy Bioreactors – much like a computer peripheral with the ability to connect to different machines via multiple port configurations. This innovative design can save a product development team 12-15 months on custom engineering single use reagent systems for their specific expansion technologies. We are excited to further accelerate our customers’ progress towards developing lifesaving medical products that incorporate stem cell technologies.”

About RoosterBio, Inc.:

RoosterBio, Inc. is a privately held stem cell tools and technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio’s products are high volume, affordable, and wellcharacterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems.

RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio’s innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio and adult stem cells, please visit www.roosterbio.com, follow on twitter (@RoosterBio), or read the blog “Democratizing Cell Technologies” (www.roosterbio.blogspot.com).

iPSC-derived cardiomyocte therapy

For more information, please contact Dr. Priya Baraniak at priya@roosterbio.com.

Rate this post

Filed Under: MSCs Tagged With: hMSC, Jon Rowley, RoosterBio

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.